S. George Simon
Business Development Consultant
Mr. Simon has over 25 years of worldwide business development, licensing, and product development experience with numerous technology, pharmaceutical, diagnostic, and medical device companies. Currently, he is the Managing Director of Q Life Sciences assisting companies with business development, licensing, and product development. In addition, he is Chairman of the Board of MesaGen, and serves as a board member of Omixon, OrthoSera, and Optisys. Most recently Mr. Simon served as Chief Business Officer at T3S Technologies, a University of Utah spin-out focusing on utilizing bacterial expression to dramatically lower the cost of manufacturing biopharmaceuticals. Previously, Mr. Simon was Executive Vice President at Myriad Genetics, Inc. where he was responsible for business development and licensing. Prior to working with Myriad Genetics, Mr. Simon was Vice President of Business Development at MorphoGen Pharmaceuticals, Inc. Additional corporate experience includes working with Jade Therapeutics, Tute Genomics, VivoRx (Abraxis BioSciences, American Pharmaceutical Partners), and Angstrom Pharmaceuticals.